Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Development (Cambridge, England)
|
June 2, 2016
Development-on-chip: in vitro neural tube patterning with a microfluidic device
Christopher J Demers, Prabakaran Soundararajan, Phaneendra Chennampally, et al.
Scientific Reports
|
September 14, 2021
A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin
Phaneendra Chennampally, Ambreen Sayed-Zahid, Prabakaran Soundararajan, et al.
Nanotechnology
|
August 10, 2011
An electron microscopy investigation of the structure of porous silicon by oxide replication
Vipin N Tondare, Brian C Gierhart, David G Howitt, et al.
Scientific Reports
|
September 30, 2021
Author Correction: A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin
Phaneendra Chennampally, Ambreen Sayed-Zahid, Prabakaran Soundararajan, et al.
Sensors and Actuators. B, Chemical
|
July 9, 2009
Nanopore with Transverse Nanoelectrodes for Electrical Characterization and Sequencing of DNA
Brian C Gierhart, David G Howitt, Shiahn J Chen, et al.
Cancer Research
|
August 7, 2013
Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110α inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancers
Joan T Garrett, Cammie R Sutton, Richard Kurupi, et al.
Journal of Medicinal Chemistry
|
July 24, 2023
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates
Jeremy R Duvall, Joshua D Thomas, Raghida A Bukhalid, et al.
Molecular Cancer Therapeutics
|
February 14, 2024
Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug Conjugates
Joshua D Thomas, Aleksandr V Yurkovetskiy, Mao Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells
Raghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster, et al.
Molecular Cancer Therapeutics
|
June 9, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer
Dorin Toader, Shawn P Fessler, Scott D Collins, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Development (Cambridge, England)
|
June 2, 2016
Development-on-chip: in vitro neural tube patterning with a microfluidic device
Christopher J Demers, Prabakaran Soundararajan, Phaneendra Chennampally, et al.
Scientific Reports
|
September 14, 2021
A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin
Phaneendra Chennampally, Ambreen Sayed-Zahid, Prabakaran Soundararajan, et al.
Nanotechnology
|
August 10, 2011
An electron microscopy investigation of the structure of porous silicon by oxide replication
Vipin N Tondare, Brian C Gierhart, David G Howitt, et al.
Scientific Reports
|
September 30, 2021
Author Correction: A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin
Phaneendra Chennampally, Ambreen Sayed-Zahid, Prabakaran Soundararajan, et al.
Sensors and Actuators. B, Chemical
|
July 9, 2009
Nanopore with Transverse Nanoelectrodes for Electrical Characterization and Sequencing of DNA
Brian C Gierhart, David G Howitt, Shiahn J Chen, et al.
Cancer Research
|
August 7, 2013
Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110α inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancers
Joan T Garrett, Cammie R Sutton, Richard Kurupi, et al.
Journal of Medicinal Chemistry
|
July 24, 2023
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates
Jeremy R Duvall, Joshua D Thomas, Raghida A Bukhalid, et al.
Molecular Cancer Therapeutics
|
February 14, 2024
Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug Conjugates
Joshua D Thomas, Aleksandr V Yurkovetskiy, Mao Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells
Raghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster, et al.
Molecular Cancer Therapeutics
|
June 9, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer
Dorin Toader, Shawn P Fessler, Scott D Collins, et al.
Page
of 3